/ Hogar / Centro de productos / Intermediarios avanzados / Anti-Cáncer /

Cabozantinib Intermediate

N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide L-malate
Número de CAS
1140909-48-3
Fórmula Molecular
C32H30FN3O10
Peso Molecular
635.6
Pureza
98%
Indicación
Cabozantinib Intermediate
Descripción del Producto

Cabozantinib S-MALATE,formerly known as XL184, trade name Cabometyx, is developed by Exelixis biopharmaceutical company in the United States.